in ACST @ .54 for a bounce, down over 30@ on trial update news. Could have bought @ .58 when the trial issue was first announced (1-13) and went up to over .75.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.